The FDA has granted approval for the IND application of Everest Medicines’ tumour-associated antigen (TAA) vaccine, EVM14.

MSD has opened a $1bn facility in Durham, in the US state of North Carolina, to increase vaccine manufacturing capacity. The ...

Here’s what happened after RFK Jr. paused Peninsula company's half-billion-dollar vaccine contract. Spoiler alert: It wasn’t ...

Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B ...

Influenza cases are up 192% over the 5-year average, and the state’s 50 flu deaths so far are the most since 2017-18, when ...

Merck has opened a $1 billion, 225,000-square-foot facility at its Durham campus dedicated to vaccine manufacturing, the drug ...

The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a ...

According to the company, the new, 225,000-square-foot expansion is a "crucial component" of a more than $12 billion infusion ...

DURHAM, N.C.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to ...

Can the continent walk the talk? **** The African Union has embarked on one of its most audacious health security missions: ...

Currently, IPV is relatively expensive to produce because it requires high levels of bio-containment to minimise the risk of leaks of live poliovirus, which could result in outbreaks. VLPs are ...

COVID-19 showed us that we urgently need more transparency in reporting adverse vaccine effects and that compensation for ...